INS and metabolic dysfunction-associated steatotic liver disease: Since cytosolic lipolysis and autophagy are both negatively regulated by insulin to exhibit functional similarity16, 18, enhancing or activating either of the lipolysis is rationally supposed to treat hepatic steatosis of NAFLD and metabolic syndrome.